Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.
Anticancer Res. 2018 Aug;38(8):4913-4918. doi: 10.21873/anticanres.12807.
Anticancer Res. 2018.
PMID: 30061269